Text Size
1267 studies found for:    "Hepatitis C"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Enrolling by invitation A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous Abbott Combination Study
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: ABT-450/r;   Drug: ABT-267;   Drug: pegylated interferon alpha-2a (pegIFN);   Drug: Ribavirin (RBV)
2 Completed TMC435350-TiDP16-C202: A Study to Assess the Activity of TMC435 on Hepatitis C Virus in Patients Who Have Never Received Treatment for Their Hepatitis C Infection.
Conditions: Hepatitis C, Chronic;   Hepatitis C;   Infection
Intervention: Drug: TMC435
3 Completed A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Conditions: Chronic Hepatitis C;   Hepatitis C;   Hepatitis C Virus (HCV)
Interventions: Drug: ABT-450/r;   Drug: ABT-333;   Drug: ribavirin
4 Completed Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C
Conditions: Coinfection With Hepatitis B Virus and Hepatitis C Virus;   Monoinfection With Hepatitis C Virus
Intervention:
5 Active, not recruiting A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
Conditions: Chronic Hepatitis C;   Compensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
6 Not yet recruiting A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   CHC;   HCV;   Hepatitis C
Interventions: Drug: VX-135;   Drug: Daclatasvir
7 Terminated Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults
Conditions: Hepatitis C, Chronic;   Hepatitis C
Intervention: Drug: GSK625433/placebo
8 Terminated A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C
Conditions: Hepatitis C;   Hepatitis C Virus
Interventions: Drug: Fluvastatin;   Drug: Peginterferon alfa2a;   Drug: ribavirin
9 Active, not recruiting A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: ABT-450/r;   Drug: ABT-333;   Drug: ABT-267;   Drug: Ribavirin (RBV)
10 Completed
Has Results 		Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031) pen;   Drug: Rebetol (ribavirin; SCH 18908)
11 Completed
Has Results 		Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690 AM1)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (Peginterferon alfa-2b);   Drug: Rebetol (Ribavirin)
12 Completed
Has Results 		Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron pen (peginterferon alfa-2b; SCH 54031);   Drug: Rebetol (ribavirin; SCH 18908)
13 Completed Effect of Low-Dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Intervention: Biological: PegIntron (peginterferon alfa-2b)
14 Completed
Has Results 		Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
Conditions: Chronic Hepatitis C;   Hepatitis C;   HIV Infections
Interventions: Biological: PEG-IFN alfa-2b;   Drug: RBV
15 Completed
Has Results 		Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031) injector;   Drug: Rebetol (ribavirin; SCH 18908)
16 Terminated
Has Results 		Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)
Conditions: Hepatitis C;   Hepatitis C, Chronic
Interventions: Biological: Peg-IFN alfa-2b;   Drug: Ribavirin
17 Terminated Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: IntronA (interferon alfa-2b; SCH 30500);   Drug: Rebetol (ribavirin; SCH 18908)
18 Completed
Has Results 		Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: peginterferon alfa-2b;   Drug: ribavirin
19 Completed Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Drug: peginterferon alfa-2b;   Drug: ribavirin
20 Completed Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Drug: PegIntron (peginterferon alfa-2b; SCH 54031);   Drug: Rebetol (ribavirin; SCH 18908)
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years